about
Vandetanib in advanced medullary thyroid cancer: review of adverse event management strategies.EGFR biomarkers predict benefit from vandetanib in combination with docetaxel in a randomized phase III study of second-line treatment of patients with advanced non-small cell lung cancer.Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers.Recent new drug approvals, part 2: drugs undergoing active clinical studies in childrenAutophagy inhibition induces enhanced proapoptotic effects of ZD6474 in glioblastomaNew developments in the diagnosis and treatment of thyroid cancer.Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid Cancer.Vandetanib: in medullary thyroid cancer.Vandetanib: a guide to its use in advanced medullary thyroid cancer.Linifanib: current status and future potential in cancer therapy.Synthesis and in vitro evaluation of [18F](R)-FEPAQ: a potential PET ligand for VEGFR2.Identification of a Peptide from In vivo Bacteriophage Display with Homology to EGFL6: A Candidate Tumor Vasculature Ligand in Breast Cancer.Emerging role of multikinase inhibitors for refractory thyroid cancer.Anilinoquinazoline inhibitors of the RET kinase domain-Elaboration of the 7-position.Mechanical induction of the tumorigenic β-catenin pathway by tumour growth pressure.
P2860
Q27692050-E8D3AFC4-245F-4839-9EED-D8D2459F2F15Q34250003-90827326-3591-40E3-9E82-9DDC6FB64001Q36677934-3845A734-26FF-4BA5-A43D-60201240CBB6Q36764984-C1D70C4E-DD6C-4493-9B24-D3E4B9F95973Q37003332-48C95B42-DAAF-4215-AFBF-B6F2CD1830E1Q37238757-EC7740BA-28A7-4316-9C5E-857F30CE7E3AQ37387829-D4499B0B-171B-443A-BA87-86C4D470391EQ38020194-3DA73911-89E8-431D-AAF7-E59B5AE76E91Q38039483-93FD618E-32DB-4BC8-81F0-53F9CB12D157Q38455525-8131EC2A-BD40-4C40-885A-F58565E4AACBQ39809361-DCA57BA1-540B-40EA-A395-6F0F7267DE17Q40867070-C7934B08-201F-4FCB-B2A8-1C038982DCEDQ41837594-E6F1191D-66EC-4A7D-AEFD-B546E6D49D9FQ41906937-17A219A2-2636-4D4F-AA9A-39756A9A526BQ55059234-7AD39AEF-2C03-47FF-8B39-E6C040DA80FF
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Vandetanib for the treatment of thyroid cancer.
@en
Vandetanib for the treatment of thyroid cancer.
@nl
type
label
Vandetanib for the treatment of thyroid cancer.
@en
Vandetanib for the treatment of thyroid cancer.
@nl
prefLabel
Vandetanib for the treatment of thyroid cancer.
@en
Vandetanib for the treatment of thyroid cancer.
@nl
P2860
P356
P1476
Vandetanib for the treatment of thyroid cancer.
@en
P2093
P2860
P356
10.1038/CLPT.2011.272
P407
P577
2011-12-07T00:00:00Z